Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and bio-evaluation of new multifunctional methylindolinone-1,2,3-triazole hybrids as anti-Alzheimer's agents
Mina Saeedi, Atefeh Maleki, Aida Iraji, et al.
Journal of Molecular Structure (2020) Vol. 1229, pp. 129828-129828
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase
Rami J. Obaid, Nafeesa Naeem, Ehsan Ullah Mughal, et al.
RSC Advances (2022) Vol. 12, Iss. 31, pp. 19764-19855
Open Access | Times Cited: 79
An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities
Shah Alam Khan, Mohammad Jawaid Akhtar, Urvashee Gogoi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 179-179
Open Access | Times Cited: 45
Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights
Najmeh Oliyaei, Marzieh Moosavi‐Nasab, Nader Tanideh, et al.
Brain Research Bulletin (2022) Vol. 193, pp. 11-21
Open Access | Times Cited: 35
Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: a new class of α-glucosidase inhibitors
Aida Iraji, Diba Shareghi-Brojeni, Somayeh Mojtabavi, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
NOVEL HETEROCYCLIC HYBRIDS AS PROMISING SCAFFOLD FOR THE MANAGEMENT OF ALZHEIMER’S DISEASE
Tyagi Alka
International Journal of Pharmacy and Pharmaceutical Sciences (2025), pp. 1-15
Open Access
A comprehensive investigation of Schiff bases and bis-α-aminophosphonates as potent agents against Alzheimer's disease by computer-aided drug discovery techniques and in vitro examinations
Emel Ekinci, Harun Çiftçi, Şevki Adem, et al.
Journal of Molecular Structure (2025), pp. 141734-141734
Closed Access
Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer’s disease
Hormoz Pourtaher, Alireza Hasaninejad, Aida Iraji
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Synthesis and biological evaluation of isatin oxime ether-tethered aryl 1H-1,2,3-triazoles as inhibitors ofMycobacterium tuberculosis
Sampath Kumar Kancharla, Saritha Birudaraju, Arani Pal, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 6, pp. 2863-2874
Closed Access | Times Cited: 22
The anti-Alzheimer potential of novel spiroindolin-1,2-diazepine derivatives as targeted cholinesterase inhibitors with modified substituents
Hormoz Pourtaher, Alireza Hasaninejad, Shahrokh Zare, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Anticholinesterase activities of novel isoindolin-1,3-dione-based acetohydrazide derivatives: design, synthesis, biological evaluation, molecular dynamic study
Ahmad Nazarian, Fahimeh Abedinifar, Haleh Hamedifar, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 4
A comprehensive review on triazole based conjugates as acetylcholinesterase inhibitors: Design strategies, synthesis, biological activity, structure activity relationships, molecular docking studies
Harmandeep Kaur Gulati, Nitish Kumar, Anchal Sharma, et al.
Journal of Molecular Structure (2023) Vol. 1284, pp. 135354-135354
Closed Access | Times Cited: 11
Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation
Sunil Kumar, Amritha Manoharan, J Jayalakshmi, et al.
RSC Advances (2023) Vol. 13, Iss. 14, pp. 9513-9529
Open Access | Times Cited: 10
Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3β level targeting Alzheimer's disease
Milad Noori, Navid Dastyafteh, Sajedeh Safapoor, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127392-127392
Closed Access | Times Cited: 9
On the application of 3d metals for C–H activation toward bioactive compounds: The key step for the synthesis of silver bullets
Renato L. Carvalho, Amanda Silva de Miranda, Mateus P. Nunes, et al.
Beilstein Journal of Organic Chemistry (2021) Vol. 17, pp. 1849-1938
Open Access | Times Cited: 21
Pyridazinones containing the (4-methoxyphenyl)piperazine moiety as AChE/BChE inhibitors: design, synthesis, in silico and biological evaluation
İrem Bozbey, Gülce Taşkor Önel, Burçin Türkmenoğlu, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 11, pp. 2021-2031
Closed Access | Times Cited: 14
Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer’s disease management; in vitro and in silico study
Ali Asadipour, Yaghoub Pourshojaei, Moein Mansouri, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Synthesis of novel aryl-substituted 2-aminopyridine derivatives by the cascade reaction of 1,1-enediamines with vinamidinium salts to develop novel anti-Alzheimer agents
Sama Loori, Hormoz Pourtaher, Abdolmohammad Mehranpour, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Quinazolinone-1,2,3-triazole-acetamide conjugates as potent α-glucosidase inhibitors: synthesis, enzyme inhibition, kinetic analysis, and molecular docking study
Sara Moghadam Farid, Aida Iraji, Somayeh Mojtabavi, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 3, pp. 520-533
Open Access | Times Cited: 7
Novel N′-substituted benzylidene benzohydrazides linked to 1,2,3-triazoles: potent α-glucosidase inhibitors
Mina Saeedi, Roshanak Hariri, Aida Iraji, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Highly efficient, catalyst-free, one-pot sequential four-component synthesis of novel spiroindolinone-pyrazole scaffolds as anti-Alzheimer agents: in silico study and biological screening
Hormoz Pourtaher, Yasaman Mohammadi, Alireza Hasaninejad, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 207-222
Closed Access | Times Cited: 6
(p‐Chlorophenyl)‐3(2H)pyridazinone Derivatives: Synthesis, in Silico, and AChE/BChE Inhibitory Activity
İrem Bozbey, Gülce Taşkor Önel, Burçin Türkmenoğlu, et al.
ChemistrySelect (2022) Vol. 7, Iss. 38
Closed Access | Times Cited: 9
Synthesis of novel hybrids of 1,2,3-triazoles-hydrazone: targeting cholinesterases and Alzheimer's related genes
Diba Shareghi-Boroujeni, Aida Iraji, Mahintaj Dara, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 15, pp. 1519-1535
Closed Access | Times Cited: 1
Azirine-triazole hybrids: selective synthesis of 5-(2H-azirin-2-yl)-, 5-(1H-pyrrol-2-yl)-1H-1,2,3-triazoles and 2-(5-(2H-azirin-2-yl)-1H-1,2,3-triazol-1-yl)pyridines
Yulia V. Krivolapova, Olesya A. Tomashenko, Liya D. Funt, et al.
Organic & Biomolecular Chemistry (2022) Vol. 20, Iss. 27, pp. 5434-5443
Closed Access | Times Cited: 8
1,3-Phenylene-based symmetrical bis(urea-1,2,3-triazole) hybrids: Synthesis, antimicrobial and in silico studies as 14α-sterol demethylase inhibitors
Nisha Poonia, Kashmiri Lal, Ashwani Kumar
Research on Chemical Intermediates (2022) Vol. 48, Iss. 4, pp. 1577-1592
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top